Rifampicin

Rifampicin, also known as rifampin, is an antibiotic used to treat a number of bacterial infections. This includes tuberculosis, leprosy, and legionella, among others. Often it is used along with other antibiotics. It is also used to prevent Haemophilus influenzae type b and meningococcal disease in those who have been exposed. Before treating someone for a long period of time testing the liver function and bloods counts are recommended. It is available by mouth and intravenously.

Common side effects include nausea, vomiting, diarrhea, and loss of appetite. It may also turn urine, sweat, and tears a red color. Liver problems or allergic reactions may occur. It is part of the recommended treatment of active tuberculosis during pregnancy even though safety is not clear in pregnancy. Rifampicin is of the rifamycin group of antibiotics. It works by stopping the making of RNA by the bacteria.

Rifampicin was first isolated in 1957 and first sold in 1971. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system. It is available as a generic medication. The wholesale cost is about 3.90 USD a month. In the United States it is expensive with a month of treatment being about 120 USD. Rifampicin is made from Amycolatopsis rifamycinica.

RIFA

RIFA may refer to:

RIFA (manufacturer)

RIFA is a Swedish electronics manufacturer which was established in 1942 and originally manufactured resistors and capacitors. RIFA manufactured parts for the Swedish radio industry during World War II. In 1947, it became incorporated in Telefonaktiebolaget LM Ericsson and became Ericsson Components in 1988 and then Ericsson Microelectronics in 2000. The company made hybrid components for telephone exchanges for the joint venture company Ellemtel between Ericsson and Televerket.

References

See also